Showing results (2571-2580 of 2,949) with videos related to

Sort By:
Pageof 295
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Neurobiology of Aging|October 26, 2005
Gene expression correlates of neurofibrillary tangles in Alzheimer's diseaseTravis Dunckley, Thomas G Beach, Keri E Ramsey, et al.
Neurology|February 14, 2018
In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob diseaseGregory S Day, Brian A Gordon, Richard J Perrin, et al.
Blood|December 6, 2012
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemiaThomas A Waldmann, Kevin C Conlon, Donn M Stewart, et al.
Archives of Neurology|December 17, 2003
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?Christopher M Clark, Sharon Xie, Jesse Chittams, et al.
Acta Neuropathologica Communications|November 28, 2018
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's diseaseDaniel Twohig, Elena Rodriguez-Vieitez, Sigrid B Sando, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's disease neuroimaging initiative: progress report and future plansMichael W Weiner, Paul S Aisen, Clifford R Jack, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Neuroimage. Clinical|December 27, 2023
Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?Gengsheng Chen, Nicole S McKay, Brian A Gordon, et al.
JAMA Neurology|May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer DiseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Pageof 295